Pneumococcal serotype epidemiology and resistance after PCV13 replacement with PCV10, Sweden
Serotypes 19A and 3 re-emerged as predominant, indicating the need for continued surveillance. Our study emphasises the risk of rapid serotype resurgence when lower-valency vaccines are reintroduced.
Authors
- Fabian Uddén (ORCID: https://orcid.org/0000-0002-2678-7687)
- Jonas Ahl
- Kristian Riesbeck (ORCID: https://orcid.org/0000-0001-6274-6965)
- Linda Yamba Yamba (ORCID: https://orcid.org/0009-0008-9369-975X)
- Wiebke Köster
- Anouschka de Bruijn
- Silvana Dalence
Institutions
- Lund University (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Journal of Infection
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1016/j.jinf.2026.106723
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Skåne County Council's Research and Development Foundation
- Moderna
- Public Health Agency
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Folkhälsomyndigheten